Long-term progression-free-survival (PFS) under sunitinib (SU) treatment for metastatic renal cell carcinoma (Sulong study): Analysis of two populations - long term responders (LR) vs. primary refractory (PR) patients

Antón Aparicio, Luis Miguel; León Mateos, Luis Ángel; Vázquez Estévez, Sergio

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/1721

ISSN: 0959-8049

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2013

Journal title

EUROPEAN JOURNAL OF CANCER

Type of content

Publicación de congreso